Ocular Therapeutix (OCUL) Leases (2019 - 2025)
Historic Leases for Ocular Therapeutix (OCUL) over the last 7 years, with Q4 2025 value amounting to $4.6 million.
- Ocular Therapeutix's Leases fell 2198.49% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.6 million, marking a year-over-year decrease of 2198.49%. This contributed to the annual value of $4.6 million for FY2025, which is 2198.49% down from last year.
- According to the latest figures from Q4 2025, Ocular Therapeutix's Leases is $4.6 million, which was down 2198.49% from $5.3 million recorded in Q3 2025.
- Ocular Therapeutix's 5-year Leases high stood at $8.0 million for Q4 2022, and its period low was $4.0 million during Q3 2022.
- Moreover, its 5-year median value for Leases was $5.8 million (2024), whereas its average is $5.8 million.
- Its Leases has fluctuated over the past 5 years, first surged by 7152.85% in 2023, then plummeted by 2198.49% in 2025.
- Over the past 5 years, Ocular Therapeutix's Leases (Quarter) stood at $4.9 million in 2021, then surged by 65.24% to $8.0 million in 2022, then fell by 19.52% to $6.5 million in 2023, then decreased by 8.14% to $5.9 million in 2024, then decreased by 21.98% to $4.6 million in 2025.
- Its Leases stands at $4.6 million for Q4 2025, versus $5.3 million for Q3 2025 and $5.9 million for Q2 2025.